Come up with a name for your new list and we'll add to it:
Ardea Biosciences was acquired by
AstraZeneca on April 23, 2012.
Ardea Biosciences is focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). In March 2000, Ardea Biosciences went public…